{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:28:55Z","timestamp":1791898135394,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2937,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1111\/j.1524-4733.2005.00041.x","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T03:28:08Z","timestamp":1122953288000},"page":"495-505","source":"Crossref","is-referenced-by-count":162,"title":["Persistence and Adherence of Medications for Chronic Overactive Bladder\/Urinary Incontinence in the California Medicaid Program"],"prefix":"10.1016","volume":"8","author":[{"given":"Yanni F.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2005.00041.x_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0749-0690(18)30118-6","article-title":"Urinary incontinence","volume":"14","author":"Busby-Whitehead","year":"1998","journal-title":"Clin Geriatr Med"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1345\/aph.19176","article-title":"Urinary incontinence","volume":"34","author":"Couture","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib30","first-page":"22","article-title":"Urinary incontinence in the aged. Part 1: Patient evaluation","volume":"47","author":"Rousseau","year":"1992","journal-title":"Geriatrics"},{"issue":"Suppl.","key":"10.1111\/j.1524-4733.2005.00041.x_bib40","first-page":"5","article-title":"The standardization of terminology of lower urinary tract function. The International Continence Society Committee on Standardization of Terminology","volume":"114","author":"Abrams","year":"1988","journal-title":"Scand J Urol Nephrol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11934-002-0093-5","article-title":"Incidence and prevalence of overactive bladder","volume":"3","author":"Rovner","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib60","author":"American Foundation for Urologic Disease"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib70","author":"National Center for Health Statistics"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib80","unstructured":"US Department of Health and Human Services. Summary Health Statistics for U.S. Adults: National Health Interview Survey 1999. Vital and Health Statistics Series 10, Number 212 (August 2003), Table 7 (p. 27)"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib90","author":"National Institute of Health"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib100","author":"Alzheimer's Disease Education and Referral Center"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib110","unstructured":"American Medical Directors Association. Clinical Practice Guidelinet: Urinary Inconinence. 1996. Columbia, MD, 1996"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib120","article-title":"Management of urinary incontinence [online]","volume":"27","author":"DeBisschop","year":"2002","journal-title":"U.S. Pharmacist"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib130","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM199504273321703","article-title":"Discontinuation of antihyperlipidemic drugs\u2014do rates reported in clinical trials reflect rates in primary care settings?","volume":"332","author":"Andrade","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib140","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed?","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinte.1994.00420040107014","article-title":"Noncompliance with congestive heart failure therapy in the elderly","volume":"154","author":"Monane","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1524-4733.1999.26005.x","article-title":"Incontinence drug utilization patterns in Quebec","volume":"2","author":"Desgagne","year":"1999","journal-title":"Canada. Value Health"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0149-2918(99)80008-3","article-title":"Treatment of urge incontinence in veterans affairs medical centers","volume":"21","author":"Malone","year":"1999","journal-title":"Clin Ther"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib180","doi-asserted-by":"crossref","first-page":":163","DOI":"10.1046\/j.1524-4733.2001.40202-249.x","article-title":"The impact of pharmacotherapy on overactive bladder symptom improvement and resource utilization [Abstract]","volume":"4","author":"Pashos","year":"2001","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1524-4733.2001.40202-247.x","article-title":"Persistence of therapy with drugs for overactive bladder [Abstract]","volume":"4","author":"Zhou","year":"2001","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records. methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib220","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1592\/phco.20.5.470.35064","article-title":"Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis","volume":"20","author":"Lawrence","year":"2002","journal-title":"Phamacotherapy"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib230","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of use of lipid-lowing medications. A cross-national study","volume":"279","author":"Avorn","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2125.2002.01563.x","article-title":"High persistence of statin use in a Danish population: compliance study 1993\u20131998","volume":"53","author":"Larsen","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2710.2002.00387.x","article-title":"Identifying patient and physician characteristics that affect compliance with antihypertensive medications","volume":"27","author":"Ren","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib260","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-0327(01)00394-9","article-title":"Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program","volume":"71","author":"Li","year":"2002","journal-title":"J Affective Disorders"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib270","series-title":"Applied Logistic Regression","author":"Hosmer","year":"1989"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.2044-8317.1992.tb00992.x","article-title":"Backward, forward and stepwise automated subset selection algorithms: frequency of obtaining authentic and noise variables","volume":"45","author":"Derksen","year":"1992","journal-title":"Br J Math Stat Psychol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/00031305.1987.10475450","article-title":"Frequency of selecting noise variables in subset regression analysis: a simulation study","volume":"41","author":"Flack","year":"1987","journal-title":"Am Stat"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib300","first-page":"46","article-title":"Comparison of stopping rules in forward \u201cstepwise\u201d regression","volume":"72","author":"Bendel","year":"1977","journal-title":"J Am Stat Assoc"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib320","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/01621459.1979.10481030","article-title":"Comparison of stopping rules in forward \u201cstepwise\u201d discriminant analysis","volume":"74","author":"Costanza","year":"1979","journal-title":"J Am Stat Assoc"},{"issue":"Suppl. 11","key":"10.1111\/j.1524-4733.2005.00041.x_bib330","first-page":"S574","article-title":"Comorbidities associated with overactive bladder","volume":"6","author":"Brown","year":"2000","journal-title":"Am J Manag Care"},{"issue":"Suppl. 2","key":"10.1111\/j.1524-4733.2005.00041.x_bib340","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1464-410X.83.s2.10.x","article-title":"Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist","volume":"83","author":"Messelink","year":"1999","journal-title":"BJU Int"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib350","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-6196(11)62382-3","article-title":"Prospective randomized controlled trial of extended-release oxybutynin chlorine and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study","volume":"76","author":"Appell","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib360","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0149-2918(00)88316-2","article-title":"An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder","volume":"21","author":"Marvin","year":"1999","journal-title":"Clin Ther"},{"issue":"Suppl. 4","key":"10.1111\/j.1524-4733.2005.00041.x_bib370","first-page":"S49","article-title":"Randomized, double-blinded study to compare extended-release oxybutynin and tolterodine for overactive bladder","volume":"97","author":"Sand","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib380","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00002512-200118070-00007","article-title":"Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine","volume":"18","author":"Abrams","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib390","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1471-0528.1997.tb12054.x","article-title":"A medium term analysis of the subjective efficacy of treatment for women with detrusor unstability and low bladder compliance","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl. 6A","key":"10.1111\/j.1524-4733.2005.00041.x_bib400","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib410","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1331\/108658002763316905","article-title":"Overactive bladder patients and role of the phamarcist","volume":"42","author":"Stewart","year":"2002","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib420","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1524-4733.2000.36006.x","article-title":"Predictors of long-term persistence on statins in a subsidized clinical population","volume":"3","author":"Catalan","year":"2000","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2005.00041.x_bib430","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S0266462300008667","article-title":"Patient decision making: the missing ingredient in compliance research","volume":"11","author":"Donovan","year":"1995","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510600435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T22:42:44Z","timestamp":1735857764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510600435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1098301510600435"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2005.00041.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}